Oxford Cancer Analytics

Curated by Signal

Provider of a platform for detection of lung cancer

Overview

Provider of a platform for detection of lung cancer. The DEcancer is an AI-based platform that detects cancer through a blood test. It analyzes liquid biopsy results for DNA, protein, and epigenetics for detecting lung cancer.

Key facts

Founded: 2018
Headquarters: Oxford, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

FreeStyle Diabetes
Manufacturer of on-demand and continuous blood glucose monitors
Life Sciences TechnologyLondon, United Kingdom
Yourgene Health
Provider of non-invasive prenatal genetic tests and genomic services
Life Sciences TechnologyManchester, United Kingdom
MyOva
Provider of nutritional supplements to improve health and wellness
Life Sciences TechnologyLondon, United Kingdom

About Oxford Cancer Analytics

What does Oxford Cancer Analytics do?

Provider of a platform for detection of lung cancer.

Where is Oxford Cancer Analytics headquartered?

Oxford Cancer Analytics is headquartered in Oxford, United Kingdom.

When was Oxford Cancer Analytics founded?

Oxford Cancer Analytics was founded in 2018.

Which sector is Oxford Cancer Analytics in?

Oxford Cancer Analytics operates in Life Sciences Technology.

Who are Oxford Cancer Analytics's competitors?

Companies similar to Oxford Cancer Analytics include FreeStyle Diabetes, Yourgene Health, and MyOva.